Human Stem Cells Institute's RAS net income for 3 months of 2023 was ₽8.28 million, down 9 times from ₽75.17 million in the previous year. Revenue fell 48.2% to ₽15.38 million versus ₽29.68 million a year earlier.
Human Stem Cells Institute's RAS net income for 3 months of 2023 was ₽8.28 million, down 9 times from ₽75.17 million in the previous year. Revenue fell 48.2% to ₽15.38 million versus ₽29.68 million a year earlier. 
e-disclosure.ru
English (US) 